Regencell Bioscience Holdings RGC
NASDAQ RGC
$6.16 -0.06 (-0.96%)
As of: Oct 1, 2026 · 10:02 AM EDT

Regencell Bioscience Holdings (RGC) Retained Earnings (2020 - 2025)

Updated

Regencell Bioscience Holdings (RGC) reported Retained Earnings of -$30.52 million for the quarter ended Dec 31, 2025.

Analysis

Regencell Bioscience Holdings (RGC) Retained Earnings (2020 - 2025) Analysis & Trends

As of Jun 30, 2025, Regencell Bioscience Holdings posted Retained Earnings of -$25.2 million.

  • By year, Retained Earnings came in at -$21.62 million in the year ended Jun 30, 2024, -$17.32 million in the year ended Jun 30, 2023, -$11.44 million in the year ended Jun 30, 2022 and -$4 million in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 171.67 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -17.33 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 12.59 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 15.69 Bn
10 Regencell Bioscience Holdings 80.94 Mn 74.16 Mn - -30.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -30.52 Mn
Jun 30, 2025 -25.20 Mn
Jun 30, 2024 -21.62 Mn
Jun 30, 2023 -17.32 Mn
Jun 30, 2022 -11.44 Mn
Jun 30, 2021 -4.00 Mn
Jun 30, 2020 -2.65 Mn
API Access

Regencell Bioscience Holdings Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=RGC&period=max&api_key=YOUR_API_KEY